Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Receivables - Net: 2023-2024

Historic Receivables - Net for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $356,000.

  • Inhibrx Biosciences' Receivables - Net fell 83.63% to $110,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $110,000, marking a year-over-year decrease of 83.63%. This contributed to the annual value of $356,000 for FY2024, which is 54.24% down from last year.
  • According to the latest figures from FY2024, Inhibrx Biosciences' Receivables - Net is $356,000, which was down 54.24% from $778,000 recorded in FY2023.
  • In the past 5 years, Inhibrx Biosciences' Receivables - Net ranged from a high of $778,000 in FY2023 and a low of $356,000 during FY2024.
  • Over the past 2 years, Inhibrx Biosciences' median Receivables - Net value was $567,000 (recorded in 2023), while the average stood at $567,000.
  • Data for Inhibrx Biosciences' Receivables - Net shows a maximum YoY slumped of 54.24% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Inhibrx Biosciences' Receivables - Net stood at $778,000 in 2023, then crashed by 54.24% to $356,000 in 2024.